Case 083Forensic accountingHard
A software company capitalises 45% of its R&D while peers capitalise 10%. Restate its EBITDA margin and free cash flow on a peer basis.
1The situation
Datrova Software has revenue of Rs 2,000 crore and operating costs other than R&D of Rs 1,300 crore. It spent Rs 400 crore on research and development this year and capitalised Rs 180 crore of it, 45%, as an intangible asset; the other Rs 220 crore went through the income statement. Three years ago it capitalised 30%. Listed peers capitalise about 10%.
Depreciation is Rs 60 crore and amortisation of past capitalised development is Rs 90 crore; on a peer policy the amortisation would be about Rs 30 crore. Cash tax is Rs 80 crore and property capex Rs 80 crore. Datrova reports free cash flow as operating cash flow less property capex, and the sector trades near 20x EV/EBITDA.
2Your task
What are Datrova's EBITDA margin, EBIT and free cash flow on a peer policy, and what does the difference do to its valuation?
Quick check
Restated to 10% capitalisation, what is Datrova's EBITDA margin?
Worked solution
Try it on paper, then open one step at a time.
30-second answerThe answer to give first
On a peer policy Datrova's EBITDA margin is 17%, not 24%, and its all-in free cash flow is Rs 140 crore, not Rs 320 crore. Expensing an extra Rs 140 crore of R&D takes EBITDA from Rs 480 crore to Rs 340 crore and EBIT from Rs 330 crore to Rs 250 crore. The cash is identical either way, but the company's free cash flow leaves out Rs 180 crore spent on engineers. At 20x EBITDA the policy is worth Rs 2,800 crore of enterprise value.
Step 1Why does capitalising R&D lift EBITDA?
Because it moves a cost below the line EBITDA stops at. A household that calls its children's tuition an investment rather than an expense does not have more money at the end of the month, but its monthly budget looks healthier. A capitalised cost never enters EBITDA; it returns later as amortisation, which EBITDA ignores by construction. Datrova expenses only Rs 220 crore of its Rs 400 crore of R&D. On a 10% policy it would expense Rs 360 crore, so its EBITDA would be Rs 340 crore, not Rs 480 crore.
Step 2Why restate before comparing margins at all?
Because a margin gap between two companies on different policies is partly a gap in bookkeeping. Restating to a common policy is the first step before comparing margins; without it you are comparing two rulers, not two businesses. Datrova's reported 24% would sit above peers at 18% and look like a better product. At 17% on the same policy, it is slightly below them. The rising capitalisation rate, 30% three years ago and 45% now, adds a second question: is Datrova building more products worth capitalising, or capitalisingRecording a cost as an asset on the balance sheet and spreading it over future years as amortisation, instead of charging it all in the year it is spent. more of the same work to protect its margin?
Step 3What happens to free cash flow?
The cash does not change: Datrova paid its engineers Rs 400 crore whatever the accounts call it. What changes is where the payment appears. Capitalised development sits in investing cash flow, so operating cash flow of Rs 400 crore looks strong. Datrova's own free cash flow, operating cash less property capex, excludes Rs 180 crore of salaries and overstates the cash the business generates by more than double. All-in, free cash flow is Rs 140 crore, and on a peer policy it is also Rs 140 crore, because the policy only moves the line.
| Rs crore | As reported | Peer basis |
|---|---|---|
| EBITDA | 480 | 340 |
| EBITDA margin | 24% | 17% |
| EBIT | 330 | 250 |
| Free cash flow, company definition | 320 | 180 |
| Free cash flow, all-in | 140 | 140 |
| Enterprise value at 20x EBITDA | 9,600 | 6,800 |
| All-in free cash flow yield on that value | 1.5% | 2.1% |
Close with the valuation. At the sector's 20x, reported EBITDA supports Rs 9,600 crore of enterprise value and restated EBITDA Rs 6,800 crore, a 29% gap created by one accounting choice. Say the limit plainly: some development really does create a durable asset, and a company building a new platform may capitalise legitimately. The test is whether amortisation keeps pace with capitalisation; here Rs 180 crore goes in and Rs 90 crore comes out, so the asset and future amortisation are both growing.
Where candidates lose it
The frequent miss is comparing Datrova's 24% margin with peers' margins as reported and calling it best in class. The interviewer gave you the capitalisation rates precisely so you would restate first.
The second is accepting Datrova's own free cash flow. Capitalised development is cash paid to people; any free cash flow that leaves it out overstates what shareholders could take out of the business.
What the interviewer asks next
- If Datrova stopped capitalising entirely next year, what would happen to reported EBITDA and to cash?
- How would you compare Datrova with a peer that capitalises nothing but pays heavily in stock options?
- Which note in the annual report would you read first to test this?
Company names and figures are illustrative.
